Chronic inflammation, including elevated tumor necrosis factor-α and interleukin-1β expression levels, is a mechanism that could contribute to the inhibition of hypothalamic GnRH and LH secretions and the development of hypogonadism in patients with T2DM [54,55]. This evidence concerns the gene PLOD1 and hypogonadism.